# This Biotech's Pill Achieves What a $34,000 IV Treatment Couldn't - Date: 2026-03-25 - Category: Biotech & Life Sciences When brexanolone won FDA approval in 2019 as the first-ever treatment specifically for postpartum depression, it felt like the opening of a new chapter in neuropsychiatry. ---